Metasphere Labs Inc.
LABZ
CNSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -892.50K | -439.50K | -2.10K | -236.60K | -386.80K |
| Total Depreciation and Amortization | 9.20K | 13.80K | 28.90K | 17.50K | 12.90K |
| Total Amortization of Deferred Charges | 53.50K | 53.50K | 53.50K | 144.30K | 119.00K |
| Total Other Non-Cash Items | 488.80K | 352.30K | 427.60K | 768.00K | 803.10K |
| Change in Net Operating Assets | -893.40K | -1.07M | -1.24M | -1.23M | -818.70K |
| Cash from Operations | -1.23M | -1.09M | -733.20K | -537.30K | -270.60K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | 0.00 | 0.00 |
| Other Investing Activities | -- | -- | -- | 26.20K | 26.20K |
| Cash from Investing | -- | -- | -- | 26.20K | 26.20K |
| Total Debt Issued | -- | -12.00K | 0.00 | -100.00K | -100.00K |
| Total Debt Repaid | -212.30K | -262.30K | -175.90K | -2.70K | 82.30K |
| Issuance of Common Stock | 1.48M | 2.41M | 2.03M | 1.06M | 1.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 925.40K | 1.57M | 1.36M | 707.70K | 728.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | 0.00 | 0.00 |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -308.80K | 479.90K | 627.20K | 196.70K | 483.60K |